DIUCAPS™

L-Phenylalanine supports natural appetite control by stimulating cholecystokinin (CCK) release, a satiety signal that tells the brain the stomach is full. A non-stimulant, non-controlled appetite suppressant for practices seeking a clean option alongside any weight management protocol.

DIUCAPS™: Non-Stimulant Appetite Control for Medical Weight Loss and GLP-1 Protocols

DIUCAPS™ delivers a therapeutic dose of L-Phenylalanine — an essential amino acid that triggers cholecystokinin (CCK) release in the gut, producing a natural feeling of fullness and food satisfaction that helps reduce overall caloric intake. Because it works through amino acid and neurotransmitter pathways rather than stimulant mechanisms, it’s a genuinely clean option for practices that need appetite control support outside the stimulant or controlled substance categories.

Ingredients

Each capsule contains:

IngredientAmount
L-Phenylalanine300 mg
Vitamin C100 mg
Pyridoxine (B6)25 mg
Pantothenic Acid (B5)50 mg

How DIUCAPS™ Works

L-Phenylalanine has been identified in research as a strong trigger for cholecystokinin (CCK) — the gut hormone that produces feelings of fullness and food satisfaction following a meal. By supporting CCK release before eating, DIUCAPS™ helps patients feel satisfied sooner and reduces the drive to overeat at each meal.

L-Phenylalanine also converts in the brain and adrenal glands to dopamine, norepinephrine, and epinephrine — neurotransmitters commonly depleted by stress and caloric restriction. Vitamin B6, Vitamin C, and Pantothenic Acid serve as the cofactors that support this conversion pathway.

Read the full mechanism in the L-Phenylalanine white paper.

Why Medical Weight Loss Clinics Choose DIUCAPS™

Non-stimulant, non-controlled: The most important clinical differentiator. DIUCAPS™ does not work through stimulant mechanisms and is not a controlled substance — making it appropriate for patients who cannot tolerate stimulants, patients with cardiovascular concerns, or practices that prefer to avoid controlled substance prescribing for appetite management.

CCK-mediated satiety: Works through a physiologically natural pathway — the same satiety hormone the body releases in response to food. A mechanism-based approach rather than a pharmacological one.

Post-GLP-1 maintenance: As patients taper off GLP-1 medications, appetite typically returns before new eating habits are fully established. DIUCAPS™ gives practices a clean, non-prescription option to support appetite management during that transition without adding another controlled medication.

Supports neurotransmitter balance: L-Phenylalanine’s conversion to dopamine and norepinephrine addresses the mood and energy depletion common in calorie-restricted patients — a practical dual benefit for medical weight loss compliance.

Who It’s For

  • Medical weight loss and bariatric clinics building a non-stimulant appetite control protocol
  • GLP-1 therapy practices supporting patients during post-medication maintenance
  • Any practice wanting a clean, non-controlled appetite suppressant as part of a broader weight management supplement line

Pairs Well With

Lipo BC™ — Lipotropic fat metabolism support alongside DIUCAPS™’s appetite control, covering both caloric intake reduction and fat processing in a single protocol.

Be-Thin™ — The sublingual lipotropic spray for practices combining between-visit metabolic support with DIUCAPS™’s CCK-driven appetite management.

D.N.S. (Doctor’s Nutritional Support) — Gymnema Sylvestre and Chromium for blood sugar and glucose metabolism support alongside appetite control — a practical pairing for patients managing carbohydrate cravings alongside caloric restriction.

FAQ

Is DIUCAPS™ a stimulant or controlled substance?
No. DIUCAPS™ works through amino acid and neurotransmitter pathways — specifically CCK-mediated satiety signaling — rather than stimulant mechanisms. It is non-stimulant and non-controlled.

What is the suggested use?
One capsule with each meal, or as directed by the ordering provider.

Is DIUCAPS™ appropriate for patients coming off GLP-1 therapy?
Yes. It’s commonly used to support appetite management during post-GLP-1 maintenance when appetite returns before new eating habits are fully established.

Can DIUCAPS™ be private labeled under our practice brand?
Yes. Minimum order is 24 bottles with a design proof ready within 2–3 business days. Contact our team to get started.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Legere: Your Partner in Success

Helpful In-Depth Research and Information

Top Quality Health Supplements Branded for Your Practice

Expert Guidance to help You Grow Your Medical Practice

Ready to Start Growing Your Practice? Let’s Chat!

Schedule a no obligation/no-pressure call to quickly increase your weight loss clinic’s revenue.